K36 Therapeutics Funding: $100M Raised, Series B (2023)
K36 Therapeutics is a Biotech company based in Cambridge, Massachusetts. It has raised $100M in total funding. Latest round: Series B.
K36 Therapeutics funding overview
K36 Therapeutics is a Biotech company based in Cambridge, Massachusetts. K36 Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for K36 Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include F-Prime Capital, Atlas Venture, Eight Roads Ventures. 3 distinct backers are named across the disclosed rounds.
K36 Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in K36 Therapeutics?
F-Prime Capital, Atlas Venture, Eight Roads Ventures are named among the investors backing K36 Therapeutics.
What was the latest K36 Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2023.
Where is K36 Therapeutics based?
K36 Therapeutics is based in Cambridge, Massachusetts.
What sector does K36 Therapeutics operate in?
K36 Therapeutics is tracked under Biotech from Cambridge, Massachusetts, with $100M in disclosed funding.
When did K36 Therapeutics last raise?
The last disclosed K36 Therapeutics round closed in January 2023 at Series B.
Every K36 Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Cambridge at a similar stage.
